Books > Science & Mathematics > Physics > Applied physics & special topics > Biophysics
|
Buy Now
Nanotheranostics for Cancer Applications (Hardcover, 1st ed. 2019)
Loot Price: R2,877
Discovery Miles 28 770
|
|
Nanotheranostics for Cancer Applications (Hardcover, 1st ed. 2019)
Series: Bioanalysis, 5
Expected to ship within 10 - 15 working days
|
This book is the first to focus specifically on cancer
nanotheranostics. Each of the chapters that make up this
comprehensive volume is authored by a researcher, clinician, or
regulatory agency member known for their expertise in this field.
Theranostics, the technology to simultaneously diagnose and treat a
disease, is a nascent field that is growing rapidly in this era of
personalized medicine. As the need for cost-effective disease
diagnosis grows, drug delivery systems that can act as
multifunctional carriers for imaging contrast and therapy agents
could provide unique breakthroughs in oncology. Nanotechnology has
enabled the development of smart theranostic platforms that can
concurrently diagnose disease, start primary treatment, monitor
response and initiate secondary treatments if required. In
oncology, chemotherapeutics have been routinely used. Some drugs
have proven effective but all carry risks of adverse side effects.
There is growing interest in using remotely triggered drug delivery
systems to limit cytotoxicity in the diseased area. This book
reviews the use of theranostic nanoparticles for cancer
applications over the past decade. First, it briefly discusses the
challenges and limitations of conventional cancer treatments, and
presents an overview of the use of nanotechnology in treating
cancer. These introductory chapters are followed by those exploring
cancer diagnosis and a myriad of delivery methods for
nanotherapeutics. The book also addresses multifunctional
platforms, treatment monitoring, and regulatory considerations. As
a whole, the book aims to briefly summarize the development and
clinical potential of various nanotheranostics for cancer
applications, and to delineate the challenges that must be overcome
for successful clinical development and implementation of such
cancer theranostics.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.